South Carolina-based Prisma Health has established a $3 million endowment to go towards an endowed chair position in molecular oncology research, according to a Feb. 13 report from the Greenville Journal.
The endowment will honor W. Larry Gluck, MD, who will retire from his position as the medical director of Prisma Health's Cancer Institute May 12. Dr. Gluck has been with the health system for nearly four decades.
While at Prisma Health, Dr. Gluck established a variety of research programs, including an institute for translational research, a center for integrative oncology and survivorship, and a center for cancer prevention and wellness.
The W. Larry Chuck, MD Endowed Chair of Translational Molecular Oncology Research position will be used to fund a physician-scientist's work, the report said.